S Mori, K Nakamura, M Shimamura, K Ohe - Journal of Clinical Medicine, 2024 - mdpi.com
Background: Immune checkpoint inhibitor (ICI) therapy is becoming the standard of care for
the treatment of advanced non-small-cell lung cancer. However, T-cell activation by ICIs …